Embryonic vascular disruption adverse outcomes: Linking high-throughput signaling signatures with functional consequences.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Reproductive Toxicology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.reprotox.2017.04.003PMID 28414088
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Screening for angiogenic inhibitors in zebrafish to evaluate a predictive model for developmental vascular toxicity.

  2017cited by this paper
• Identification of vascular disruptor compounds by analysis in zebrafish embryos and mouse embryonic endothelial cells.

  2017cited by this paper
• My Winding Road: From Microbiology to Toxicology and Environmental Health.

  2016cited by this paper
• In vivo screening and discovery of novel candidate thalidomide analogs in the zebrafish embryo and chicken embryo model systems

  2016cited by this paper
• Technological Advances in Cardiovascular Safety Assessment Decrease Preclinical Animal Use and Improve Clinical Relevance.

  2016cited by this paper
• Analysis of the Effects of Cell Stress and Cytotoxicity onIn Vitro Assay Activity Across a Diverse Chemical and Assay Space

  2016cited by this paper
• Thalidomide (5HPP-33) suppresses microtubule dynamics and depolymerizes the microtubule network by binding at the vinblastine binding site on tubulin.

  2015cited by this paper
• Fgf and Esrrb integrate epigenetic and transcriptional networks that regulate self-renewal of trophoblast stem cells

  2015cited by this paper
• Phenotypic screening of the ToxCast chemical library to classify toxic and therapeutic mechanisms

  2014cited by this paper
• Predictivity of dog co-culture model, primary human hepatocytes and HepG2 cells for the detection of hepatotoxic drugs in humans.

  2014cited by this paper
• Comparison of effects of anti-angiogenic agents in the zebrafish efficacy–toxicity model for translational anti-angiogenic drug discovery

  2014cited by this paper
• Endothelial estrogen receptor isoforms and cardiovascular disease.

  2014cited by this paper
• Multidimensional in vivo hazard assessment using zebrafish.

  2014cited by this paper
• The Tox21 robotic platform for the assessment of environmental chemicals--from vision to reality.

  2013cited by this paper
• A Computational Model Predicting Disruption of Blood Vessel Development

  2013cited by this paper
• Update on EPA's ToxCast program: providing high throughput decision support tools for chemical risk management.

  2012cited by this paper
• Zebrafish developmental screening of the ToxCast™ Phase I chemical library.

  2012cited by this paper
• Novel compound SK-1009 suppresses interleukin-6 expression through modulation of activation of nuclear factor-kappaB pathway.

  2012cited by this paper
• Feasibility study of the zebrafish assay as an alternative method to screen for developmental toxicity and embryotoxicity using a training set of 27 compounds.

  2012cited by this paper
• Inter-laboratory assessment of a harmonized zebrafish developmental toxicology assay - progress report on phase I.

  2012cited by this paper
• Angiogenic factors in preeclampsia and related disorders.

  2012cited by this paper
• Fluorothalidomide: a characterization of maternal and developmental toxicity in rabbits and mice.

  2011cited by this paper
• Methionine aminopeptidase 2 is required for HSC initiation and proliferation.

  2011cited by this paper
• Regulation of angiogenesis by a non-canonical Wnt-Flt1 pathway in myeloid cells

  2011cited by this paper
• Developmental and pathological angiogenesis.

  2011cited by this paper
• Disruption of embryonic vascular development in predictive toxicology.

  2011cited by this paper
• Predictive models of prenatal developmental toxicity from ToxCast high-throughput screening data.

  2011cited by this paper
• Environmental Impact on Vascular Development Predicted by High-Throughput Screening

  2011cited by this paper
• Anatomic and etiological classification of congenital limb deficiencies

  2011cited by this paper
• Teratogenic mechanisms of medical drugs.

  2010cited by this paper
• Morphological score assignment guidelines for the dechorionated zebrafish teratogenicity assay.

  2010cited by this paper
• Fetal malformations and early embryonic gene expression response in cynomolgus monkeys maternally exposed to thalidomide.

  2010cited by this paper
• Whole embryo culture: a "New" technique that enabled decades of mechanistic discoveries.

  2010cited by this paper
• Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation

  2009cited by this paper
• LXR-activating oxysterols induce the expression of inflammatory markers in endothelial cells through LXR-independent mechanisms.

  2009cited by this paper
• Maternal administration of anti-angiogenic agents, TNP-470 and Angiostatin4.5, induces fetal microphthalmia

  2009cited by this paper
• Kinetic cell-based morphological screening: prediction of mechanism of compound action and off-target effects.

  2009cited by this paper
• A critical analysis of current in vitro and in vivo angiogenesis assays

  2009cited by this paper
• Profiling Bioactivity of the ToxCast Chemical Library Using BioMAP Primary Human Cell Systems

  2009cited by this paper
• Descriptive epidemiologic features shared by birth defects thought to be related to vascular disruption in Texas, 1996-2002.

  2008cited by this paper
• Novel tubulin-polymerization inhibitor derived from thalidomide directly induces apoptosis in human multiple myeloma cells: possible anti-myeloma mechanism of thalidomide.

  2008cited by this paper
• Hedgehog signalling in vascular development

  2008cited by this paper
• New tubulin polymerization inhibitor derived from thalidomide: implications for anti-myeloma therapy.

  2008cited by this paper
• Targeted gene disruption of methionine aminopeptidase 2 results in an embryonic gastrulation defect and endothelial cell growth arrest

  2006cited by this paper
• A thalidomide analogue with in vitro antiproliferative, antimitotic, and microtubule-stabilizing activities

  2006cited by this paper
• Sulforhodamine B colorimetric assay for cytotoxicity screening

  2006cited by this paper
• Angiogenesis inhibitors derived from thalidomide.

  2005cited by this paper
• No tail co-operates with non-canonical Wnt signaling to regulate posterior body morphogenesis in zebrafish

  2004cited by this paper
• Signaling hierarchy downstream of retinoic acid that independently regulates vascular remodeling and endothelial cell proliferation.

  2004cited by this paper
• Prediction of in vivo synergistic activity of antiangiogenic compounds by gene expression profiling.

  2002cited by this paper
• Phase I trial of the angiogenesis inhibitor TNP-470 for progressive androgen-independent prostate cancer.

  2001cited by this paper
• A Wnt5a pathway underlies outgrowth of multiple structures in the vertebrate embryo.

  1999cited by this paper
• Epidermal growth factor, vascular endothelial growth factor and progesterone promote placental development in rat whole-embryo culture

  1998cited by this paper
• Placental abnormalities in mouse embryos lacking the orphan nuclear receptor ERR-β

  1997cited by this paper
• Mammalian craniofacial embryology in vitro.

  1997cited by this paper
• Analysis of heart development in cultured rat embryos.

  1997cited by this paper
• Critical components of the female reproductive pathway are suppressed by the angiogenesis inhibitor AGM-1470

  1997cited by this paper
• Mechanisms of normal and abnormal neurulation: evidence from embryo culture studies.

  1997cited by this paper
• Disruption of Msx‐1 and Msx‐2 reveals roles for these genes in craniofacial, eye, and axial development

  1997cited by this paper
• Cell fate and morphogenetic movement in the late mouse primitive streak.

  1996cited by this paper
• Stages of embryonic development of the zebrafish

  1995cited by this paper
• Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

  1995cited by this paper
• Thalidomide is an inhibitor of angiogenesis.

  1994cited by this paper
• The zebrafish as a model system to study cardiovascular development.

  1994cited by this paper
• Aging of tubulin at neutral pH: stabilization by colchicine and its analogues.

  1992cited by this paper
• Difference in teratogenic potency of ethylenethiourea in rats and mice: relative contribution of embryonic and maternal factors.

  1989cited by this paper
• Quantitation of rat embryonic development in vitro: a morphological scoring system.

  1981cited by this paper
• The action of some nucleotoxic substances on pregnancy.

  1956cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• An evaluation framework for new approach methodologies (NAMs) for human health safety assessment.

  2020cites this paper
• Characterizing cleft palate toxicants using ToxCast data, chemical structure, and the biomedical literature.

  2019cites this paper
• Food for Thought . . . 3 S – Systematic , Systemic , and Systems Biology and Toxicology

  2018cites this paper